Novo Nordisk to acquire Akero Therapeutics for its experimental liver disease drug
Novo Nordisk will acquire Akero Therapeutics for up to $5.2 billion to add experimental MASH drug efruxifermin and accelerate growth under CEO Mike Doustdar.
Dolphins legend Dan Marino reveals liver disease diagnosis
Dan Marino, 64, was diagnosed with metabolic dysfunction-associated steatohepatitis (MASH) and has improved through weight loss, dietary changes, and resumed exercise.
Screen Grabs: Tribute to 100 years of Robert Altman, a cynic's New Hollywood takeover - 48 hills
Robert Altman's M*A*S*H introduced a new, immersive storytelling style, mixing gore and humor, while subverting traditional portrayals of war, establishing Altman as a unique voice in cinema.
Patrick Adiarte, Actor Seen in Musicals and on M*A*S*H,' Dies at 82
Patrick Adiarte's diverse career spanned Broadway, television, and film, showcasing his versatility through various roles reflecting different ethnic backgrounds, leaving a significant impact.